title: Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.
abstract: Valine, leucine, and isoleucine are essential branched chain amino acids (BCAAs). When BCAA metabolism is genetically impaired in human, serum levels of BCAA and/or their metabolites rise considerably, causing severe neurological dysfunction. The first step in BCAA catabolism is catalyzed by branched chain aminotransferase (BCAT). Hypervalinemia and hyperleucine-isoleucinemia caused by BCAT gene mutation in human have not been reported previously. A 25-year-old man presented with headache complaints and mild memory impairment for about six years. Brain MRI showed symmetric white matter abnormal signals. Metabolic studies revealed remarkably elevated plasma valine and leucine concentrations. Maple syrup urine disease (MSUD) diagnosis was not supported since all genes for the branched-chain α-keto acid dehydrogenase complex (BCKD) gene were normal. Interestingly, two heterogeneous BCAT2 gene mutations were found in the patient, including c.509G > A (p.Arg170Gln) and c.790G > A (p.Glu264Lys). In addition, c.509G > A (p.Arg170Gln) and c.790G > A (p.Glu264Lys) were found in his father and mother, respectively, suggesting an autosomal recessive disorder. BCAT2 functional studies demonstrated that the two BCAT2 gene mutations resulted in decreased BCAT2 enzyme activity. After treatment with vitamin B6, the levels of BCAA, especially valine were remarkably decreased and brain MRI lesions were improved. These findings suggest a new type of branched chain amino acid metabolism disorder. This rare case provides great insight into the further understanding of BCAA metabolism and its defect in human. BCAT2 gene mutations can cause hypervalinemia and hyperleucine-isoleucinemia, which are associated with brain white matter lesions.
authors: Department of Neurology, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, People's Republic of China.
authors: X L
authors: XL
authors: Wang
authors: C J
authors: CJ
authors: Li
authors: Y
authors: Y
authors: Xing
authors: Y H
authors: YH
authors: Yang
authors: J P
authors: JP
authors: Jia
mesh_terms: D000328:Adult; D000592:Amino Acid Metabolism, Inborn Errors / Q000150:complications / Q000235:genetics*; D000597:Amino Acids, Branched-Chain / Q000378:metabolism; D001483:Base Sequence; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000235:genetics*; D008297:Male; D008375:Maple Syrup Urine Disease / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism; D015778:Minor Histocompatibility Antigens; D008969:Molecular Sequence Data; D020125:Mutation, Missense; D011257:Pregnancy Proteins / Q000235:genetics* / Q000378:metabolism; D012640:Seizures / Q000150:complications / Q000235:genetics*; D000637:Transaminases / Q000235:genetics* / Q000378:metabolism; D014633:Valine / Q000235:genetics / Q000652:urine*
chemical_list: D000597:Amino Acids, Branched-Chain; D015778:Minor Histocompatibility Antigens; D011257:Pregnancy Proteins; D000637:Transaminases; C424463:BCAT2 protein, human; D014633:Valine
references: Clin Biochem. 2009 Apr;42(6):462-6
references: 19121297
references: J Nutr. 2005 Jun;135(6 Suppl):1557S-64S
references: 15930469
references: Glia. 1997 Sep;21(1):92-8
references: 9298851
references: J Nutr. 2006 Jan;136(1 Suppl):324S-30S
references: 16365107
references: Tohoku J Exp Med. 1963 Oct 25;81:46-55
references: 14077060
references: Clin Chem. 1995 Jan;41(1):62-8
references: 7813082
references: J Clin Invest. 2004 Feb;113(3):434-40
references: 14755340
references: J Nutr. 2006 Jan;136(1 Suppl):207S-11S
references: 16365084
references: Biochemistry. 2002 Jul 23;41(29):9070-8
references: 12119021
references: Neurochem Int. 2006 Dec;49(7):640-50
references: 16822590
references: Mol Genet Metab. 2004 May;82(1):69-75
references: 15110325
references: Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E64-76
references: 12965870
references: Biochim Biophys Acta. 2003 Nov 20;1639(3):232-8
references: 14636955
references: Curr Treat Options Neurol. 2003 Jul;5(4):329-341
references: 12791200
references: J Neurochem. 2012 Dec;123(6):997-1009
references: 23043456
references: Tohoku J Exp Med. 1965 Dec 25;87(3):322-31
references: 5863810
references: Neuroradiology. 2003 Jun;45(6):393-9
references: 12736767
references: Biochim Biophys Acta. 2003 Apr 11;1647(1-2):61-5
references: 12686109
references: Front Med. 2013 Mar;7(1):53-9
references: 23385611
references: J Biol Chem. 1998 Feb 27;273(9):4982-9
references: 9478945